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Abstract
Oxidation of RNA can be effected by two different techniques: a photochemical, electron-transfer
method termed “flash-quench” and direct oxidation by metal oxo complexes. The flash-quench
method produces selective oxidation using a metal photosensitizer, tris(bipyridyl)ruthenium(III)
trichloride (Ru(bpy)33+), and quencher, pentaamminechlorocobalt(III) chloride (Co(NH3)5Cl2+). We
have optimized the flash-quench technique for the following RNAs: tRNAPhe, human ferritin iron-
responsive element (IRE), and a mutated human ferritin IRE. We have also employed a chemical
footprinting technique involving the oxoruthenium(IV) complex (Ru(tpy)(bpy)O2+ (tpy = 2,2′,2″-
terpyridine; bpy = 2,2′-bipyridine)) to oxidize guanine. Comparison of the two methods shows that
the flash-quench technique provides a visualization of nucleotide accessibility for a static
conformation of RNA while the Ru(tpy)(bpy)O2+ complex selectively oxidizes labile guanines and
gives a visualization of a composite of multiple conformations of the RNA structure.
Introduction
The oxidation of DNA has been studied extensively and is implicated in aging, cancer,
atherosclerosis, and neurological disorders.1-5 The electron transfer chemistry of DNA has
been studied extensively using many techniques including cyclic voltammetry,6-8 transient
absorption spectroscopy,9,10 emission spectroscopy,11,12 chronoamperometry,6 pulse
radiolysis,10 electron paramagnetic resonance spectroscopy,2,13 as well as stopped-flow
spectrophotometry,8 and the flash-quench method.4,7,9-11,14-17
Recently, there has been much attention toward RNA, but its electron-transfer chemistry has
not been studied comprehensively. The increased interest is due to the identification of oxidized
RNA species present in brain tissue affected by neurological disorders such as Alzheimer’s
disease (AD) and the possibility of RNA as a therapeutic drug target.1-3,18-24 Recently, lipid
peroxidation and oxidation of proteins, DNA and RNA has been found in the vulnerable regions
of the brains of patients with AD and mild cognitive impairment.1-3,20 This oxidation occurs
early in the diseases and can lead to disruptive changes in protein synthesis and ribosome
function. Although it is unknown what effect the oxidized RNA has, these observations suggest
that RNA may be used as a potential drug target in these neurological disorders.
Several small molecules, such as the macrolide and aminoglycoside antibiotics, are known to
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interactions.19,21-24 This observation has led to the investigation of ways to identify small
molecules that bind to RNA through the use of such techniques as combinatorial libraries,19,
22,24 computational methods,18,19,21 and NMR spectroscopy.18,19,23,24 Footprinting
techniques such as the use of RNases, transition metal complexes, and photo-oxidation,25,26
can be used to identify the binding sites of small molecules to the RNA,13,19,22,27 aiding in
the use of RNA as a drug target.
Our lab has used footprinting to identify a small molecule, yohimbine, that effectively binds
to human ferritin iron responsive element (IRE) and disrupts iron regulatory protein (IRP)
binding to the IRE, increasing the rate of biosynthesis of ferritin.27 The binding of yohimbine
to the IRE was identified by a chemical footprinting method involving the Ru(tpy)(bpy)O2+
(tpy = 2,2′,2″-terpyridine; bpy = 2,2′-bipyridine) complex that is a strong enough oxidant to
oxidize DNA,27,28 particularly the guanine bases due to their low redox potential (1.1 V vs
Ag/AgCl).5 The Ru(tpy)(bpy)O2+ complex targets solvent-accessible sites prone to cation
binding via an inner-sphere reaction with guanine8,13,14,27,29 and can also interact with the
stem of the RNA in an electrostatic manner.30 The Ru(tpy)(bpy)O2+ complex likely binds to
the surface of the minor groove in DNA31 with a binding constant of 660 M−1.32,33
The ferritin IRE is a well-studied RNA sequence; originally its structure was proposed to be a
stem-loop structure based on computational calculations34,35 (Figure 1A). This stem-loop
structure was confirmed by nuclease mapping experiments, crystallography and NMR
spectroscopy.34-37 Its structure consists of a central conserved sequence, 5′-
C14A15G16U17G18N19-3′, which comprises the hexaloop in the hairpin structure, while the
base-paired stem varies between different IRE mRNAs.23,34,36,38 The hexaloop contains a
C14-G18 base pair across the loop while G16 is unpaired and solvent-exposed. The human
ferritin IRE has a stem structure consisting of the bulged nucleotides G0, U6 and C8, a wobble
base-pair between bases U10 and G23, and base-paired guanines at positions 7, 22, 26, and
27.37,39 We have also studied a mutated form of the human ferritin IRE (MIRE), in which the
U6 and C8 were deleted from the sequence (Figure 1B). This gave a conformation of a bulged
U1 and the same conserved hexaloop consisting of 5′-C12A13G14U15G16N17-3′ and bulge at
G0 as IRE as predicted by Mfold40,41 and RNAstructure 4.2.42
Another RNA sequence that has been studied in our lab using the Ru(tpy)(bpy)O2+ complex
is transfer RNA with a bound phenylalanine (tRNAPhe) (Figure 1C).13 The tRNAPhe RNA was
chosen for its well-known structure and the ability to change its conformation from semi-
denatured to a folded form simply by changing the salt concentrations and annealing
temperatures.13,43
In addition to chemical oxidation with Ru(tpy)(bpy)O2+, DNA can be oxidized by transition
metal complexes such as Ru(bpy)33+ (bpy = 2,2′-bipyridine) and other similar Ru and Rh
complexes can oxidize guanines, which must be photochemically generated and reacted with
DNA in situ. The Ru(bpy)33+ complex is known to oxidize guanines via an outer-sphere
electron transfer and interacts with DNA in an electrostatic manner as an external binder9,11,
17 with a binding constant of 0.8 × 103 M−1. The Ru(bpy)33+ complex can be generated
photochemically using the flash-quench technique. Traditional flash-quench methodology, as
demonstrated by Barton’s group, selectively oxidizes guanine bases in double-stranded DNA
using an exogenous electron donor, an exogenous electron acceptor (quencher), and visible
light (Scheme 1).9,16 Visible light excites Ru(bpy)32+ to *Ru(bpy)32+ (the electron donor that
is interacting with DNA), which then transfers an electron to the oxidative quencher creating
the unstable Ru(bpy)33+ with a lifetime of 600 ns.15 In the presence of RNA, Ru(bpy)33+
oxidizes guanine, reducing Ru(bpy)33+ back to the stable Ru(bpy)32+ state.7,9-11,14-17
Irreversible reactions of the guanine radical with oxygen or water yield oxidative lesions that
can then be analyzed by gel electrophoresis.10
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The flash-quench technique is commonly used for DNA, but its methodology has not been
explored for RNA. Since human ferritin IRE RNA and tRNAPhe form folded secondary
structures with stem regions, parallels can be drawn between double-stranded DNA and the
stem regions of these RNA strands. The IRE and tRNAPhe stem regions may allow the
exogenous electron donor metal complex to bind in an electrostatic manner as an external
binder along the phosphate backbone.6,11,12 With this reasoning, we have developed and
optimized the use of the flash-quench reaction for RNA. This method may reveal more
information pertaining to the electron-transfer chemistry of RNA, how metal complexes
interact with RNA, and give greater insight as to how small molecules bind and interact with
RNA as potential drug target. We contrasted the flash-quench method to oxidation with Ru
(tpy)(bpy)O2+. While Ru(tpy)(bpy)O2+ is in a pseudo-stable state with a lifetime > 1h,32,46,
47 Ru(bpy)32+ has to be converted to its excited state, the unstable Ru(bpy)33+ (with a lifetime
of 600 ns) in order to oxidize RNA or DNA. We have determined that the flash-quench
technique can successfully map particular RNA structures (determined via comparison with
the Ru(tpy)(bpy)O2+ complex). While the flash-quench technique is not a comprehensive
footprinting technique on its own, using it in conjunction with another footprinting technique
allows us a better overall visualization of the conformation of different RNA structures and
their sites of lability.
Experimental Details
General
Plasmid purification kits were purchased from Qiagen. XL-10 Ultracompetent cells were
purchased from Stratagen. Dra I, T4 RNA ligase, and T4 RNA ligase buffer were purchased
from New England Biolabs. Proteinase K, phenol/chloroform, linear acrylamide, GlycoBlue,
Superase-In, MEGAshortscript T7 Kit, RNase A (1 μg/ml), RNase T1 (1 U/μl), alkaline
hydrolysis buffer, 10% SDS, 10 × phosphate buffered saline (PBS) buffer and high
concentration T7 RNA polymerase were obtained from Applied Biosystems. QuikChange
mutagenesis kit was purchased from Stratagene. Reliant fast-lane agarose gel systems were
purchased from Lonza. RNA spin columns were purchased from Roche. (5′-32P)pCp was
obtained from Perkin Elmer. Ultrafree-MC centrifugal filter devices were purchased from
Millipore. Synthetic oligonucleotides were purchased from Lineburger Comprehensive Cancer
Center Nucleic Acids Core Facility. DNA was stored in 1 X tris(hydroxymethyl)aminomethane
(Tris) and ethylenediamine tetraacetic acid (EDTA) (TE) buffer. RNA and labeled RNA were
stored in DEPC-H2O. RNA and DNA concentrations were determined by absorbance
measurements at 260 and 280 nm. The [Ru(bpy)3]Cl2, [Co(NH3)5Cl]Cl2, yohimbine HCl and
aniline were obtained from Sigma-Aldrich and used as received. All aqueous solutions were
prepared with DEPC-H2O obtained from Invitrogen. All other chemicals used were molecular
biology grade. Concentrations were determined from a Cary 300 Bio UV-Visible
Spectrophotometer. Photolysis was done on a 68810 Arc Lamp supply with a 350 W Hg lamp
and 368 nm cutoff filter from Newport Oriel Instruments. All other chemicals used were
molecular biology grade and all aqueous solutions were prepared using autoclaved MilliQ
water.
IRE studies
The plasmid containing the T7 promoter sequence 5′ to the human ferritin IRE sequence was
constructed in our lab. This DNA was used as a template for T7 RNA polymerase-mediated
transcription. RNA was 3′-end-labeled using T4 RNA ligase and (5′-32P)pCp overnight at 4°
C.48 The IRE used was a 50-base oligonucleotide containing the sequence, 5′-GGA AAG UCG
GGG UUU CCU GCU UCA ACA GUG CUU GGA CGG AAC CCG GCU UU-3′.
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IRE bound to yohimbine studies
Yohimbine hydrochloride was obtained from Sigma and dissolved in DEPC-treated water in
concentrations ranging from 1-40 μM. Yohimbine was added to folded IRE RNA and incubated
for 15 min at room temperature in Tris-HCl buffer (50 mM, pH 7.4). The concentrations used
in the Ru(tpy)(bpy)O2+ assay were from 1-20 μM.27
tRNAPhe studies
Yeast tRNAPhe was obtained from Sigma and dissolved in 0.3 M sodium acetate, 10 mM Tris-
HCl (pH 7.4), 10 mM EDTA, and 0.5% SDS. The tRNAPhe was then purified by several phenol-
chloroform extractions and recovered by ethanol precipitation.48 RNA was 3′-end-labeled
using T4 RNA ligase and (5′-32P)pCp. Unlabeled tRNAPhe (0.25 μM) and labeled tRNAPhe
(0.875 μM) were placed in 10 mM sodium phosphate (pH 7.0) and 10 mM MgCl2. The
Mg2+ is necessary for tRNA to fold into its native structure. The tRNAPhe was folded into its
native form by heating the mixture at 50°C for 8 min and slow cooling to room temperature.
Semidenatured tRNAPhe was prepared by heating unlabeled tRNAPhe and labeled tRNAPhe in
10 mM sodium phosphate (pH 7.0) at 50°C for 8 min with immediate cooling on ice.
MIRE studies
The plasmid containing the T7 promoter sequence 5′ to the human ferritin IRE sequence was
constructed in our lab. This DNA was then altered at the U6 and C8 sites using site-directed
mutagenesis from pCRII-TOPO vector, subcloned into pBluescript IISK (+) and used as a
template for T7 RNA polymerase-mediated transcription. The nucleotides U6 and C8 were
removed to create a more streamlined, less flexible hairpin loop. The final MIRE used was a
48-base oligonucleotide containing the sequence, 5′-GGA AAG UCG GGG UUU CCG UUC
AAC AGU GCU UGG ACG GAA CCC GGC UUU-3′. RNA was 3′-end-labeled using T4
RNA ligase and (5′-32P)pCp.
Flash-quench procedure
Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate chloride ([Ru(bpy)3]Cl2) and
pentaamminechlorocobalt(III) chloride ([Co(NH3)5Cl]Cl2) were purchased from Aldrich and
used as received. Metals were dissolved either in sodium phosphate buffer (pH 7) or in tris
(hydroxymethyl)aminomethane (Tris) buffer (pH 7). The unlabeled RNA (0.25 μM) and the
labeled RNA (0.875 μM) were folded at 95°C for 5 min and slowly cooled to room temperature.
When yohimbine HCl was added, folded RNA and yohimbine HCl were incubated at room
temperature for 15 min. The photosensitizer, Ru(bpy)32+ (225-425 μM), and the quencher, Co
(NH3)5Cl2+ (2250-4250 μM), were added to the folded RNA. Photolysis occurred in the
presence of a 350 W Hg lamp with a 368 nm cutoff filter and water filter for varying exposure
lengths. The reaction was quenched with 95% ethanol and 3M sodium acetate pH 5.2, causing
irreversible oxidative lesions and then treated with aniline. Oxidation was visualized on a 20%
(7 M urea) denaturing polyacrylamide gel and quantified using ImageQuant 5.2 software. Gels
were run with RNA ladders were constructed using respective 3′ end-labeled RNA via
enzymatic cleavage by RNase A, RNase T1 and alkaline hydrolysis from protocol and the
following controls: labeled RNA only, folded RNA only, no photolysis treatment, no aniline
treatment, folded RNA treated only with Ru(bpy)32+, and folded RNA treated only with Co
(NH3)5Cl2+.
Ru(tpy)(bpy)O2+ procedure
The Ru(tpy)(bpy)OH22+ was synthesized according to published procedures.46,47,49 The Ru
(tpy)(bpy)O2+ oxidant was made through bulk electrolysis by holding the aqueous solution of
Ru(tpy)(bpy)OH22+ at 0.85 V vs. Ag/AgCl for 10 min in 10 mM sodium phosphate (pH 7).
46,47 The unlabeled RNA (0.25 μM) and the labeled RNA (0.875 μM) were folded in Tris-HCl
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buffer (50 mM, pH 7.4) by heating to 95°C for 5 min followed by slow cooling to room
temperature. When yohimbine HCl was added, folded RNA and yohimbine HCl were
incubated at room temperature for 15 min. Varying amounts of Ru(tpy)(bpy)O2+ (100-260
μM) were added and reacted for 5, 15, or 30 min. The reaction was quenched with 95% ethanol
and treated with aniline. Oxidation was visualized on 20% (7 M urea) denaturing
polyacrylamide gels and quantified using ImageQuant 5.2.27 Gels were run with RNA ladders
created by treatment of the respective RNA with RNase A, RNase T1 and alkaline hydrolysis
and the following controls: labeled RNA only, folded RNA only, and no aniline treatment
Isotope Effect studies
To demonstrate kinetic isotope effects, the flash-quench reaction was performed with RNA,
chemical reagents and buffers prepared in D2O (99.9 atom % purchased from Sigma-Aldrich)
by dissolving them in D2O and adjusting the pD (pH + 0.4). These reactions were compared
to similar reactions prepared using MilliQ water.
Results and Discussion
We utilized two methods to assess the structure of RNA in this study, the flash-quench method
and oxidation by the Ru(tpy)(bpy)O2+ complex. In the flash-quench method, photo-excited Ru
(bpy)32+ is oxidatively quenched by Co(NH3)5Cl2+ to produce Ru(bpy)33+, which is relatively
short-lived. The Ru(bpy)33+ complex is then reduced back to Ru(bpy)32+ by the oxidation of
guanine.4,7,9-11,14-17 This method has been used previously only for DNA; here we show that
oxidation of guanine also occurs in RNA and produces an aniline-labile lesion that is visible
with gel electrophoresis.
In the Ru(tpy)(bpy)O2+ method, oxidation of guanine occurs via an inner-sphere reaction of
the oxo ligand of the metal complex with the nucleobase. In DNA, 1′-oxidation of the sugar
can also occur, but the 2′-hydroxyl of the ribose of RNA deactivates the 1′-hydrogen, allowing
only direct base oxidation of guanine.7,8,13,14,27-29,32,33 The guanine oxidation occurs
preferentially at solvent-accessible sites, particularly those prone to cation binding.8,13,14,27,
29 The Ru(tpy)(bpy)O2+ complex is more stable than Ru(bpy)33+ and therefore oxidizes nucleic
acids on a longer time scale, potentially targeting labile sites that become solvent-accessible
during the reaction due to fluctuations in the nucleic acid structure.
The well-characterized13,23,34-39,43-45,50-52 RNA structures IRE and tRNAPhe were chosen
to test these two methods, both of which contain base-paired stem regions. The tRNAPhe has
the additional advantage of forming a secondary structure known as the semi-denatured form
and in the presence of MgCl2 can form a tertiary structure known as the native or folded form.
The two structures, which differ by their flexibility and tertiary structure, may provide an
indication of how the flash-quench and Ru(tpy)(bpy)O2+ methods proceed. Previously, our lab
detected binding of small molecules, such as yohimbine and promazine, to IRE through various
footprinting techniques.27,53 We also explored a more streamlined, less flexible, altered piece
of IRE (MIRE) where the U6 and C8 bulges of IRE were deleted to further investigate the flash-
quench and Ru(tpy)(bpy)O2+ methods.
IRE studies
The flash-quench method was applied to the IRE by photolyzing radiolabeled IRE in the
presence of Ru(bpy)32+ and Co(NH3)5Cl2+ in Figure 2A. We used denaturing polyacrylamide
gel electrophoresis (PAGE) to image the guanine oxidation and ImageQuant 5.2 software to
quantitate the intensities of the cleavage. In Figure 2A the PAGE gel shows oxidation occurring
at guanine positions 0, 7, 16, 18, 22, 23, 26, and 27 with greater cleavage occurring at guanines
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in bulge and loop regions of the RNA. The quantitation of these intensities of cleavage is
displayed in Figure 2C.
Cleavage of the IRE was further investigated using the Ru(tpy)(bpy)O2+ method where
radiolabeled IRE is incubated with Ru(tpy)(bpy)O2+ to generate oxidized guanines.27,28 The
Ru(tpy)(bpy)O2+ method yields cleavage at guanine positions 0, 7, 16, 18, 22, 23, 26 and 27
for IRE (Figure 2B). Greater cleavage again occurs in the structural areas of loops and bulges,
as shown in the gel in Figure 2B and the quantitation in Figure 2C.
Comparing the flash-quench and Ru(tpy)(bpy)O2+ methods shows similar guanine cleavage
for the two methods; however, when the intensity is quantitated and compared in Figure 2C,
guanines at positions 7, 16, 18 and 22 exhibit greater cleavage intensities under flash-quench
conditions while guanines at positions 23, 26, and 27 show greater intensities of cleavage with
the Ru(tpy)(bpy)O2+ method. The flash-quench method shows a higher degree of selectivity
to the preferred nucleotides compared to Ru(tpy)(bpy)O2+. Since Ru(tpy)(bpy)O2+ does not
have the short lifetime of Ru(bpy)33+, the RNA can “breathe”, or change its conformation, and
oxidation of more sites can occur as they become solvent-accessible. Thus, Ru(tpy)(bpy)O2+
targets more nucleotide conformations within the RNA, thereby producing more cleavages of
similar intensity, compared to the greater selectivity of Ru(bpy)33+.
Previously, when the flash-quench reaction with Ru(bpy)33+ was compared to the Ru(tpy)(bpy)
O2+ method for DNA oxidation, the differences in intensity were not seen, most likely due to
the accessibility of the two DNA oxidation methods: 1′-oxidation of the sugar and direct base
oxidation.7,28 The combination of having both modes of oxidation causes the increase in the
intensity of oxidation for the Ru(tpy)(bpy)O2+ to be similar to that of the flash-quench reaction.
7,28 An additional increase in oxidation also occurred in one of the previously mentioned
studies due to the presence of 7-deazaguanine in the DNA sequence, which allows both outer-
sphere and inner-sphere oxidation by Ru(tpy)(bpy)O2+ to occur.7
tRNAPhe studies
To demonstrate the versatility of the flash-quench method for simple RNA structures as well
as more complicated structures, we tested the secondary clover-leaf and the native tertiary
structures of tRNAPhe.13,43-45,50-52 In Figures 3A and B, the flash-quench method depicts the
oxidation of D16/17, G18-20, A21, m22G26, A35/36, A38, Ψ39, G43, A44, G45, m7G46, G51, G53,
Ψ55, C56, G57, G65, A67, U69, and C70 in both conformations. The biggest difference between
these flash-quench gels is that the semi-denatured form shows greater intensity than the highly
folded form at most sites of oxidation, even though the intensities of oxidation are very similar
between the semi-denatured and folded forms, which becomes apparent when quantified in
Figure 3C.
Our lab has previously investigated the two conformations of tRNAPhe using the Ru(tpy)(bpy)
O2+ method where oxidation occurs at positions D16/17, G18-20, A21, m22G26, A35/36, A38,
Ψ39, G43, A44, G45, m7G46, G51, G53, Ψ55, C56, G57, G65, A67, U69, and C70 (Figures 4A, B,
and C).13 Greater oxidation is seen in the semi-denatured form at m22G26, Ψ39, Ψ55, C56,
G57, A67, U69, and C70. Many of these sites of oxidation occur in the TΨC loop, which
according to the X-ray crystal structure, are protected from oxidation in the folded form.13,
44,45,50,51 Our results are consistent with earlier studies showing that sites within the TΨC loop
have increasing accessibility upon denaturation of tRNAPhe.13,52
When we compare the flash-quench and Ru(tpy)(bpy)O2+ methods of the two conformations
of tRNAPhe, differences in the two mechanisms become evident. In the folded and semi-
denatured forms (Figure 5), there is a greater increase in oxidation at most sites with the flash-
quench mechanism upon denaturation. In particular, at sites G18-20, A35/36, A38, G45, and
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G57, we see the greatest differences in oxidation between the flash-quench and Ru(tpy)(bpy)
O2+ methods in both the folded and semi-denatured forms. These sites are nucleotides that are
not base-paired in the folded form of tRNAPhe and are found within the D, anticodon, variable,
and TΨC loops.51 These results also support our interpretation from the IRE study that the
flash-quench method is oxidizing the RNA in a faster reaction where only a limited population
of highly labile, solvent accessible regions of RNA are oxidized due to the limited lifetime of
Ru(bpy)33+, while the Ru(tpy)(bpy)O2+ method reacts with the RNA in a slower reaction,
allowing a visualization of nucleotides as the RNA changes its conformation, but still targeting
labile, solvent accessible sites with greater frequency.
MIRE studies
To further confirm the results we obtained with tRNAPhe, we studied a piece of RNA with less
diverse structural properties. A more streamlined RNA, MIRE, was obtained by deleting the
uridine and cytosine of the IRE at positions 6 and 8, respectively. These deletions cause a
uridine at position 1 to bulge out of the stem of the RNA and become more prone to oxidation,
as indicated by Mfold40,41 and RNAstructure 4.242 programs. When the strand was oxidized
by the flash-quench method, cleavage occurred at the uridine in position 1 and at guanines in
positions 0, 14, and 16, as seen in Figure 6A and quantified in Figure 6C. Similarly, in Figure
6B, we see oxidation with the Ru(tpy)(bpy)O2+ method at the uridine in position 1, and the
guanines in positions 0, 14, and 16. This is very similar to the results acquired from the flash-
quench method, but upon comparison, the flash-quench method shows greater cleavage
intensity at all positions, further supporting our hypothesis that similar sites will be targeted
by Ru(bpy)33+ and Ru(tpy)(bpy)O2+, but due to the shorter lifetime of Ru(bpy)33+ higher
oxidation intensities occur at sites that are in the correct orientations. The streamlined structure
of MIRE RNA likely causes the RNA to have less lability in solution, hindering the Ru(tpy)
(bpy)O2+ from oxidizing with greater intensity.
IRE bound to yohimbine studies
Previously, we examined the binding of small molecules for applications in RNA therapeutics.
27 We found that the small molecules yohimbine and promazine bind to IRE and increase the
translational efficiency of ferritin.27,53 Yohimbine’s binding site was obtained by incubating
radiolabeled IRE with increasing amounts of the small molecule followed by incubation with
Ru(tpy)(bpy)O2+.27 The resulting gel showed decreases in cleavage intensity at the guanine
positions that were bound to yohimbine. We decided to use this experiment not only for the
purpose of further examination of the differences between the Ru(tpy)(bpy)O2+ and flash-
quench methods but also to see if the flash-quench method could be used as an effective
chemical footprinting method for RNA. When the IRE with yohimbine was oxidized with the
flash-quench method, oxidation occurred at guanine positions 0, 7, 16, 18, 22, 23, 26 and 27
(Figure 7A), as with IRE without yohimbine (Figures 2A, B and C). However, we do not see
a decrease in the intensity of any of the bands with an increasing concentration of yohimbine.
Quantitation of these results is shown in Figure 7B. Using the Ru(tpy)(bpy)O2+ method,
oxidation was seen at guanine positions 0, 7, 16, 18, 22, 23, 26, and 27, but a noticeable decrease
in intensity occurred at guanine positions 16, 18, 23, and 27 and is quantified in Figure 7B.27
Oxidation at sites 23 and 27 was reduced by over 50%, and oxidation at site 16 decreased by
about 9% with yohimbine binding.27
Visualization of the interaction of the RNA with yohimbine using the Ru(bpy)32+/3+ flash-
quench methodology showed no difference between the RNA in the presence or absence of
yohimbine (Figures 7A and B) while Ru(bpy)(tpy)O2+ was able to footprint yohimbine binding
to the IRE. This indicates that the way a transition metal oxidant binds to the RNA and the
resulting predominant method of electron transfer correlate with its ability to footprint. The
Ru(bpy)33+ complex can only bind electrostatically to RNA9,11,17; thus outer-sphere electron
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transfer can only occur via electron tunneling that does not require intimate contact between
guanine and the metal complex.54,55 This outer-sphere electron transfer allows nucleotides to
be oxidized in regions where yohimbine is bound. The Ru(tpy)(bpy)O2+ covalently bonds to
RNA and oxidizes RNA through inner-sphere electron transfer.8,13,14,27,29,31 RNA oxidation
can, therefore, inhibited by the binding of yohimbine or another small molecule nearby. A
possible alternative explanation for these observations could be Ru(bpy)32+ interfering with
yohimbine binding to the RNA. However, yohimbine was incubated with RNA before any
metal complexes were added, giving ample time for yohimbine to bind to the RNA without
interference.
Isotope Effect studies
The isotope effect of IRE oxidation was studied with the flash-quench and Ru(tpy)(bpy)O2+
mechanisms. A normal isotope effect occurs when, in this case, a greater intensity of oxidation
occurs in the H2O reactions in comparison with the deuterated samples. This reflects the
importance of proton transfer to occur to allow the irreversible guanine oxidation in contrast
to the deuterated samples where the heavier mass of the deuterium and the lower zero-point
energy of the OD vibration make it harder for proton transfer to occur.56-59 The natural variance
of the isotope effect found within a polynucleotide shows the solvent accessibility of the
individual nucleotide, thus a more solvent accessible nucleotide should have a normal isotope
effect.28 These fluctuations in isotope effect were previously found using rabbit IRE DNA and
RNA with Ru(tpy)(bpy)O2+ and primer extension methods,28 here we have verified those
results with direct labeling of human IRE RNA.
In Figures 8A, B, C, and D normal isotope effects occurred at the guanines in the bulge and
loop regions at positions 0, 16, and 18 for both flash-quench and Ru(tpy)(bpy)O2+ methods,
most likely due to the importance of proton transfer due to the nucleotides accessibility. At
guanine positions 7, 26, and 27, an inverse isotope effect was found for the flash-quench
samples and at guanine positions 22 and 23 an inverse isotope effect was observed for Ru(tpy)
(bpy)O2+ samples; however, the inverse isotope effects seen for guanine at position 23 for Ru
(tpy)(bpy)O2+ and for guanine at position 27 for flash-quench are not statistically significant.
The increased number of inverse isotope effect sites with the flash-quench reaction may again
verify that the limited lifetime of the Ru(bpy)33+ complex hinders its ability to oxidize
nucleotides in contrast to the Ru(tpy)(bpy)O2+ method.
Conclusions
In this work, we have demonstrated that the flash-quench method can be used for RNA just as
with DNA and proteins. In these experiments with three structurally different pieces of RNA,
we found similar nucleotides were oxidized for the flash-quench and Ru(tpy)(bpy)O2+
methods. The more labile nucleotides of an RNA sequence have a greater propensity to be
oxidized than less labile bases in both the flash-quench and Ru(tpy)(bpy)O2+ methods. The
flash-quench mechanism usually yields greater oxidation especially at highly labile, solvent
accessible nucleotides; however, its ability to oxidize nucleotides is limited by the lifetime of
Ru(bpy)33+. In contrast, the Ru(tpy)(bpy)O2+ complex has greater accessibility to nucleotides
throughout an RNA sequence due to its longer lifetime, allowing the visualization of a larger
population of RNA structural forms. However, Ru(tpy)(bpy)O2+ is limited by its size, shape,
and charge, allowing the Ru(tpy)(bpy)O2+ method to pinpoint regions where the flexibility of
the oligoribonucleotide has been compromised due to small molecule binding and therefore
serve to footprint its position. It is evident that both methods can give structural information
about RNA and together show highly labile, solvent accessible sites and changes in RNA
conformations.
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These results can be explained by the nanosecond time scale in which the flash-quench
oxidation occurs, only allowing nucleotides in the correct conformations during that time to
be oxidized and causing the targeting of highly labile, solvent-accessible nucleotides at a great
frequency.7,28 In this process Ru(bpy)33+ oxidizes guanines via an outer-sphere electron
transfer, so oxidation may occur over longer distances due to electron tunneling, however, due
to this mechanism of oxidation Ru(bpy)33+ is unable to detect and footprint the binding of
small molecules that can protect guanine nucleotides from intimate contact with the metal
complex. The Ru(tpy)(bpy)O2+ complex targets solvent-accessible sites prone to cation
binding via an inner-sphere reaction with guanine due to its size, shape, and charge on relatively
long time scale, causing these sites to be targeted with greater frequency and allowing direct
electron transfer that detects and footprints small molecules bound to RNA.
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Structures of RNA as predicted by Mfold40,41 and RNAstructure 4.242: (A) human ferritin iron
responsive element (IRE), (B) mutated human ferritin iron responsive element (MIRE), and
(C) the structure of tRNAPhe, as determined from x-ray crystallography.44,45
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Flash-quench mechanism adapted from references 9 and 16.
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Flash-quench and Ru(tpy)(bpy)O2+ reactions of IRE. (A) Flash-quench reaction where Lanes
1-6 are controls: Lane 1 = labeled RNA only, Lane 2 = folded RNA only, Lane 3 = no photolysis,
Lane 4 = no aniline treatment, Lane 5 = folded RNA treated only with Ru(bpy)32+, Lane 6 =
folded RNA treated only with Co(NH3)5Cl2+, and RNA ladders are indicated above the lanes.
For Lanes 7-9, folded RNA was treated with [Ru(bpy)32+] = 225 μM, [Co(NH3)5Cl2+] = 2250
μM, and photolysis for 11 min for flash-quench oxidation. (B) The Ru(tpy)(bpy)O2+ reaction
where [Ru(tpy)(bpy)O2+] = 100 μM in Lanes 1-3, and (C) quantitation of (A) and (B), cleavage
intensities are in arbitrary units normalized to the cleavage occurring at G0. Statistically
significant (P < 0.05) differences in intensity were found between Ru(bpy)32+ flash-quench
and Ru(tpy)(bpy)O2+ methods at G7, G16, G18, G22, G23, G26, and G27. Error bars represent
the standard deviation. Each reaction was run in triplicate. Flash-quench is abbreviated FQ and
Ru(tpy)(bpy)O2+ is abbreviated RuO for the legend.
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Flash-quench reactions of tRNAPhe: (A) semi-denatured tRNAPhe with [Ru(bpy)32+] = 225
μM, [Co(NH3)5Cl2+] = 2250 μM in Lanes 1-3, (B) native folded form of tRNAPhe with [Ru
(bpy)32+] = 225 μM, [Co(NH3)5Cl2+] = 2250 μM in Lanes 1-3, and (C) quantiation of both
forms of tRNAPhe with the flash-quench method. The differences between the semi-denatured
and folded tRNAPhe were not statistically significant for P < 0.05. Each reaction was run in
triplicate. Error bars represent the standard deviation. Cleavage intensities are in arbitrary units
normalized to G43. Flash-quench is abbreviated FQ, semi-denatured tRNAPhe is abbreviated
s-d, and the native folded form of tRNAPhe is abbreviated folded.
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Ru(tpy)(bpy)O2+ reactions of tRNAPhe: (A) semi-denatured tRNAPhe with [Ru(tpy)(bpy)
O2+] = 100 μM, in Lanes 1-3, (B) native folded form of tRNAPhe with [Ru(tpy)(bpy)O2+] =
100 μM, in Lanes 1-3, and (C) chart depicting the quantiation of both forms of tRNAPhe with
the Ru(tpy)(bpy)O2+ method. Statistically significant (P < 0.05) differences in intensities were
found for nucleotides m22G26, Ψ39, Ψ55, A67, U69, and C70 between the semi-denatured and
folded tRNAPhe. Each reaction was run in triplicate. Error bars represent the standard deviation.
Cleavage intensities are in arbitrary units normalized to G43. Ru(tpy)(bpy)O2+ is abbreviated
RuO, semi-denatured tRNAPhe is abbreviated s-d, and the native folded form of tRNAPhe is
abbreviated folded.
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Quantiation of both forms of tRNAPhe with the flash-quench and Ru(tpy)(bpy)O2+ methods.
Statistically significant (P < 0.05) differences between the flash-quench and Ru(tpy)(bpy)
O2+ treated semi-denatured tRNAPhe were found for G18-20, A21, A35/36, A38, Ψ39, G45,
m7G46, C56, G57, and C70. For folded tRNAPhe statistically significant (P < 0.05) differences
between the flash-quench and Ru(tpy)(bpy)O2+ methods were found for G18-20, m22G26,
A35/36, G45, Ψ55, C56, G57, U69, and C70. All reactions were run in triplicate. Error bars
represent the standard deviation. Cleavage intensities are in arbitrary units normalized to
G43. Flash-quench is abbreviated FQ, Ru(tpy)(bpy)O2+ 43 is abbreviated RuO, semi-denatured
tRNAPhe is abbreviated s-d, and the native folded form of tRNAPhe is abbreviated folded.
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Flash-quench and Ru(tpy)(bpy)O2+ reactions of MIRE: (A) flash-quench reaction where [Ru
(bpy)32+] = 225 μM, [Co(NH3)5Cl2+] = 2250 μM in Lanes 1-3, (B) the Ru(tpy)(bpy)O2+
reaction where [Ru(tpy)(bpy)O2+] = 100 μM in Lanes 1-3,27 and (C) quantitation chart
comparing (A) and (B), cleavage intensities are in arbitrary units normalized to the cleavage
occurring at G0. Statistically significant (P < 0.05) differences between Ru(bpy)32+ flash-
quench and Ru(tpy)(bpy)O2+ methods were found for nucleotides U1, G6, G14 and G16. Each
reaction was run in triplicate. Error bars represent standard deviation. Flash-quench is
abbreviated FQ and Ru(tpy)(bpy)O2+ is abbreviated RuO for the legend.
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Flash-quench reaction of yohimbine bound to IRE in comparison to Ru(tpy)(bpy)O2+: (A)
flash-quench oxidation where [Ru(bpy)32+] = 225 μM, [Co(NH3)5Cl2+] = 2250 μM in Lanes
1-5, [yohimbine] = 0 μM in Lane 1, 1 μM in Lane 2, 5 μM in Lane 3, 10 μM in Lane 4, 20
μM in Lane 5, and (B) quantitation of (A) the flash-quench reaction in comparison to the Ru
(tpy)(bpy)O2+ oxidation (from reference 27) of yohimbine bound to IRE. Cleavage intensities
are in arbitrary units normalized to the cleavage occurring at G0. Each reaction was run in
triplicate and error bars represent the standard deviation. Flash-quench is abbreviated to FQ
and Ru(tpy)(bpy)O2+ is abbreviated to RuO for the legend.
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Isotope effect on the flash-quench and Ru(tpy)(bpy)O2+ reactions of IRE: (A) flash-quench
reaction where Lanes 1-3 are the flash-quench reactions in H2O with [Ru(bpy)32+] = 225 μM,
[Co(NH3)5Cl2+] = 2250 μM. Lanes 4-6 contain the deuterated samples with [Ru(bpy)32+] =
225 μM, [Co(NH3)5Cl2+] = 2250 μM, (B) the Ru(tpy)(bpy)O2+ reaction where [Ru(tpy)(bpy)
O2+] = 100 μM in Lanes 1-3 for the Ru(tpy)(bpy)O2+ reactions in H2O and in Lanes 4-6 for
the deuterated samples,27 (C) the quantitation of flash-quench gel in (A), and (D) quantitation
of the Ru(tpy)(bpy)O2+ gel in (B). For the quantitations in (C) and (D), cleavage intensities
are in arbitrary units normalized to the total population of cleavage found in each individual
lane. Statistically significant (P < 0.05) differences were found between the H2O and D2O
reactions for the flash-quench method at nucleotides G0, G16, G18, G22, and G26. Statistically
significant differences in intensities occurred at G26 and G27 between the H2O and D2O
reactions for the Ru(tpy)(bpy)O2+ method. All reactions were run in triplicate and error bars
represent the standard deviation. Flash-quench is abbreviated FQ and Ru(tpy)(bpy)O2+ is
abbreviated RuO for the legend.
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